Cargando…
Diagnosing multiple system atrophy: current clinical guidance and emerging molecular biomarkers
Multiple system atrophy (MSA) is a rare and progressive neurodegenerative disorder characterized by motor and autonomic dysfunction. Accurate and early diagnosis of MSA is challenging due to its clinical similarity with other neurodegenerative disorders, such as Parkinson’s disease and atypical park...
Autores principales: | Goolla, Meghana, Cheshire, William P., Ross, Owen A., Kondru, Naveen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570409/ https://www.ncbi.nlm.nih.gov/pubmed/37840912 http://dx.doi.org/10.3389/fneur.2023.1210220 |
Ejemplares similares
-
Bereitschaftspotential in Multiple System Atrophy
por: Yang, Yi-Chien, et al.
Publicado: (2021) -
Neuropathology and molecular diagnosis of Synucleinopathies
por: Koga, Shunsuke, et al.
Publicado: (2021) -
Rethinking the reliability and accuracy of biomarkers in CNS-originating EVs for Parkinson's disease and multiple system atrophy
por: Taha, Hash Brown
Publicado: (2023) -
First symptoms in multiple system atrophy
por: McKay, Jake H., et al.
Publicado: (2018) -
The Shaking Palsy of the Larynx—Potential Biomarker for Multiple System Atrophy: A Pilot Study and Literature Review
por: Warnecke, Tobias, et al.
Publicado: (2019)